Duquesne Family Office added Insmed as a smaller biotech buy and purchased shares in Natera as a top holding.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Duquesne Family Office added Insmed as a smaller biotech buy and purchased shares in Natera as a top holding.